埃布斯坦异常的临床表现和治疗方法
Nikolaus A Haas1, David J Driscoll2, Silke Rickert-Sperling3
1Department of Pediatric Cardiology and Intensive Care, Ludwig Maximilians University, Munich, Germany. Nikolaus.haas@med.uni-muenchen.de.
Advances in experimental medicine and biology
|June 17, 2024
概括
埃布斯坦异常是一种罕见的先天性心脏缺陷,影响三管和右心室. 这种情况发生在约21万分之一的出生中,需要专门的医疗理解.
科学领域:
- 心脏病学 心脏病学
- 遗传性心脏缺陷 遗传性心脏缺陷
- 儿童心脏病学 儿童心脏病学
背景情况:
- 埃布斯坦异常是一种罕见的先天性心脏缺陷,占所有心脏形病例的不到1%.
- 它大约影响21万活产中的1例,突出其罕见性.
- 这种情况是由三管在右心室内的异常定位来定义的.
研究的目的:
- 为了阐明埃布斯坦异常的结构特征.
- 描述典型的呈现和相关的心脏异常.
- 为进一步的研究和临床管理提供基本的理解.
主要方法:
- 对埃布斯坦异常现有文献的审查.
- 对心声回声和解剖学描述的分析.
- 综合有关患病率和病理生理学的数据.
主要成果:
- 埃布斯泰恩异常涉及一个形的三角门,向下移位.
- 右心室经常不发达和肌病性 (减弱).
- 相关的心脏异常可能同时存在,影响临床表现.
结论:
- 埃布斯坦异常是一种复杂的先天性心脏病,涉及三管和右心室结构.
- 了解解剖学变异对于诊断和治疗计划至关重要.
- 需要进一步的研究来探索长期的结果和治疗策略.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
136
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
136
Esophageal Perforation-II: Clinical Manifestations and Management
54
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
54
Esophageal Strictures-II: Clinical Features and Management
61
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
61
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Gastroesophageal Reflux Disease II: Clinical Features and Management
68
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
68
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
153
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
153


